SS
LEGN icon

SBI Securities’s Legend Biotech LEGN Stock Holding History

SBI Securities’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$289 Sell
10
-126
-93% -$3.4K ﹤0.01% 3207
2026
Q1 		$2.46K Buy
136
+134
+6,700% +$2.56K ﹤0.01% 2341
2025
Q4 		$43 Hold
2
– – ﹤0.01% 3606
2025
Q3 		$65 Hold
2
– – ﹤0.01% 3637
2025
Q2 		$71 Hold
2
– – ﹤0.01% 3634
2025
Q1 		$68 Hold
2
– – ﹤0.01% 3564
2024
Q4 		$65 Buy
+2
New +$83 ﹤0.01% 3575

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

SBI Securities's LEGN Position: Q2 2026 in Review

SBI Securities reduced its Legend Biotech (LEGN) stake by 93% in Q2 2026, selling an estimated $3.4K and leaving 10 shares worth $289. The position accounts for ﹤0.01% of the portfolio, ranked #3207.

SBI Securities first reported a position in LEGN in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.46K in Q1 2026. 218 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • SBI Securities held 10 shares of Legend Biotech worth $289 as of Q2 2026.
  • SBI Securities sold 126 Legend Biotech shares in Q2 2026, an estimated $3.4K.
  • Legend Biotech made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #3207 holding.
  • SBI Securities first reported a position in Legend Biotech in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Legend Biotech position peaked at $2.46K in Q1 2026.
  • 218 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.